Ascites Treatment Method Challenged In New Inter Partes Review Petition

(May 2, 2018, 9:43 AM EDT) -- ALEXANDRIA, Va. — A patented method of administering the peptide drug terlipressin as a continuous infusion to ascites patients on an outpatient basis is both anticipated and rendered obvious by prior...
To view the full article, register now.